1 |
Cholecalciferol
| 1件: Cholecalciferol Cholecalciferol | 5件: CHOLECALCIFEROL CHOLECALCIFEROL; COLECALCIFEROL; Multivitamin; Vitamin D; Vitamin D3; | 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 24件: 6 6, 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 60, 65, 84, 85, 96, 97, 98, 162, 202, 228, 271, 298, 299 |
2 |
Budesonide
| 1件: Budesonide Budesonide | 4件: BUDESONIDE BUDESONIDE; Entocort; Jorveza; Symbicort; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 9件: 66 66, 93, 94, 95, 96, 97, 98, 228, 299 |
3 |
Famotidine
| 1件: Famotidine Famotidine | 2件: FAMOTIDINA FAMOTIDINA; Famotidine; | 1件: HRH2 HRH2 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction 💬 | 6件: 6 6, 46, 61, 86, 98, 107 |
4 |
Lansoprazole
| 1件: Lansoprazole Lansoprazole | 1件: Lansoprazole Lansoprazole; | 2件: ATP4A ATP4A, ATP4B 💬 | 4件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | 7件: 63 63, 71, 85, 98, 166, 222, 299 |
5 |
Loratadine
| 1件: Loratadine Loratadine | 2件: Loratadina Loratadina; Loratadine; | 1件: HRH1 HRH1 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 4件: 13 13, 46, 89, 98 |
6 |
Mesalamine
| 1件: Mesalazine Mesalazine | 10件: 5-AminoSalicylic Acid 5-AminoSalicylic Acid; 5-ASA; ASACOL; Mesalamine; MESALAZINA; Mesalazine; Mesalazinum; MEZAVANT; Pentasa; Salofalk; | - | - | 5件: 46 46, 96, 97, 98, 164 |
7 |
Sucralfate
| 1件: Sucralfate Sucralfate | 1件: Sucralfate Sucralfate; | - | - | 1件: 98 98 |
8 |
Sevoflurane
| 1件: Sevoflurane Sevoflurane | 1件: Sevoflurane Sevoflurane; | - | - | 7件: 6 6, 21, 22, 34, 98, 225, 296 |
9 |
Propofol
| 1件: Propofol Propofol | 2件: Propofol Propofol; Propofol Injection; | 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 9件: 6 6, 21, 22, 34, 46, 70, 75, 98, 296 |
10 |
Beclomethasone dipropionate
| 1件: Beclomethasone dipropionate Beclomethasone dipropionate | 2件: BECLOMETASONE DIPROPIONATE BECLOMETASONE DIPROPIONATE; Beclomethasone dipropionate; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 85 85, 97, 98 |
11 |
Mometasone furoate
| 1件: Mometasone furoate Mometasone furoate | 3件: Mometasone Mometasone; Mometasone furoate; Nasonex; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 98 98, 162 |
12 |
Sirolimus
| 1件: Sirolimus Sirolimus | 3件: RAPAMUNE RAPAMUNE; Rapamycin; Sirolimus; | 1件: MTOR MTOR 💬 | 51件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 40件: 2 2, 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 |
13 |
Fluticasone propionate
| 1件: Fluticasone propionate Fluticasone propionate | 3件: Flovent Flovent; Fluticasone; FLUTICASONE PROPIONATE; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 98 98, 228 |
14 |
Infliximab
| 1件: Infliximab Infliximab | 6件: Flixabi Flixabi; INFLECTRA; Infliximab; Remicade; REMSIMA; Zessly; | 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 27件: 35 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 |
15 |
Arginine
| 2件: Arginine Arginine, L-arginine | 6件: Arginina Arginina; Arginine; L-Arg; L-Arginin; L-arginine; R-Gene; | - | - | 20件: 46 46, 46, 58, 65, 67, 67, 78, 78, 96, 96, 97, 97, 98, 98, 113, 113, 210, 251, 299, 299 |
16 |
Mepolizumab
| 1件: Mepolizumab Mepolizumab | 2件: MEPOLIZUMAB MEPOLIZUMAB; NUCALA; | 1件: IL5 IL5 💬 | 13件: Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬 | 4件: 44 44, 45, 98, 162 |
17 |
Omalizumab
| 1件: Omalizumab Omalizumab | 2件: Omalizumab Omalizumab; XOLAIR; | 1件: FCER1A FCER1A 💬 | 4件: Asthma Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬 | 7件: 46 46, 53, 65, 98, 162, 226, 299 |
18 |
Citalopram
| 1件: Citalopram Citalopram | 1件: Citalopram Citalopram; | 1件: SLC6A4 SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 7件: 6 6, 8, 13, 18, 46, 98, 127 |
19 |
Cromoglicic acid
| 1件: Cromoglicic acid Cromoglicic acid | 4件: Cromoglicate Cromoglicate; Cromoglycate; Cromolyn; Cromolyn Sodium; | - | - | 3件: 2 2, 85, 98 |
20 |
Esomeprazole
| 1件: Esomeprazole Esomeprazole | 3件: Esomeprazole Esomeprazole; Nexium; Omeprazole; | 2件: ATP4A ATP4A, ATP4B 💬 | 4件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | 8件: 13 13, 46, 86, 98, 107, 113, 298, 299 |
21 |
Fluticasone
| 1件: Fluticasone Fluticasone | 1件: Fluticasone Fluticasone; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 98 98, 228, 299 |
22 |
Losartan
| 1件: Losartan Losartan | 3件: Cozaar Cozaar; Losartan; LOSARTAN POTASSIUM; | 1件: AGTR1 AGTR1 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 17件: 17 17, 19, 36, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
23 |
Mometasone
| 1件: Mometasone Mometasone | 1件: Mometasone Mometasone; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 98 98, 162 |
24 |
Montelukast
| 1件: Montelukast Montelukast | 3件: Montelukast Montelukast; MONTELUKAST SODIUM; Singulair; | 1件: CYSLTR1 CYSLTR1 💬 | 2件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬 | 8件: 6 6, 13, 46, 61, 63, 85, 98, 228 |
25 |
Potassium
| 1件: Potassium Potassium | 1件: Potassium Potassium; | - | - | 13件: 36 36, 46, 66, 67, 88, 93, 94, 98, 115, 167, 179, 215, 235 |
26 |
Dexlansoprazole
| 1件: Dexlansoprazole Dexlansoprazole | 1件: Dexlansoprazole Dexlansoprazole; | 2件: ATP4A ATP4A, ATP4B 💬 | 4件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | 1件: 98 98 |
27 |
Reslizumab
| 1件: Reslizumab Reslizumab | 1件: Reslizumab Reslizumab; | 1件: IL5 IL5 💬 | 13件: Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬 | 2件: 44 44, 98 |
28 |
Benralizumab
| 1件: Benralizumab Benralizumab | 2件: Benralizumab Benralizumab; Fasenra; | 1件: IL5RA IL5RA 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | 5件: 44 44, 45, 98, 162, 299 |
29 |
Dupilumab
| 1件: Dupilumab Dupilumab | 2件: Dupilumab Dupilumab; Dupixent; | 1件: IL4R IL4R 💬 | 8件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | 5件: 51 51, 97, 98, 160, 162 |
30 |
Etrasimod
| 1件: Etrasimod Etrasimod | 1件: Etrasimod Etrasimod; | 5件: S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬 | 3件: FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 3件: 96 96, 97, 98 |
31 |
Tezepelumab
| 1件: Tezepelumab Tezepelumab | 3件: AMG 157 AMG 157; MEDI9929; Tezepelumab; | 1件: TSLP TSLP 💬 | 2件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬 | 1件: 98 98 |
32 |
Vonoprazan
| 1件: Vonoprazan Vonoprazan | 1件: Vonoprazan Vonoprazan; | 2件: ATP4A ATP4A, ATP4B 💬 | 4件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | 2件: 63 63, 98 |
33 |
Lirentelimab
| 1件: Lirentelimab Lirentelimab | 1件: Lirentelimab Lirentelimab; | 1件: SIGLEC8 SIGLEC8 💬 | - | 1件: 98 98 |